2026/08/05
Since 2010, the REBACIN® R&D team has presented research findings at 12 consecutive International Papillomavirus Conferences (IPVCs). Four studies were selected for oral presentation: at the 27th IPVC in Berlin (2011), the 32nd IPVC in Sydney (2017), the 33rd IPVC in Barcelona (2020), and the 37th IPVC in Bangkok (2025), reflecting the continued international academic interest in REBACIN® research.
REBACIN® at 12 Consecutive IPVC Conferences, 2010–2025
